Академический Документы
Профессиональный Документы
Культура Документы
mosquitoes
Malaria is transmitted among humans by female mosquitoes
of the genus Anopheles. There are approximately 3,500
species of mosquitoes grouped into 41 genera, only 30-40
species transmit malaria (i.e., are "vectors") in nature.
Female mosquitoes take blood meals to carry out egg
production, and such blood meals are the link between the
human and the mosquito hosts in the parasite life cycle.
The successful development of the malaria parasite in the
mosquito (from the "gametocyte" stage to the "sporozoite"
stage) depends on several factors.
The most important is ambient temperature and humidity
(higher temperatures accelerate the parasite growth in the
mosquito) and whether the Anopheles survives long enough to
allow the parasite to complete its cycle in the mosquito host
("sporogonic" or "extrinsic" cycle, duration 10 to 18 days).
Differently from the human host, the mosquito host does not
suffer noticeably from the presence of the parasites.
Life Cycle in Human
The natural ecology of malaria involves malaria parasites
infecting successively two types of hosts: humans and
female Anopheles mosquitoes.
In humans, the parasites grow and multiply first in the liver
cells and then in the red cells of the blood.
In the blood, successive broods of parasites grow inside the
red cells and destroy them, releasing daughter parasites
("merozoites") that continue the cycle by invading other red
cells.
The blood stage parasites are those that cause the
symptoms of malaria.
When certain forms of blood stage parasites
("gametocytes") are picked up by a female Anopheles
mosquito during a blood meal, they start another, different
cycle of growth and multiplication in the mosquito.
Life Cycle in Mosquito
After 10-18 days, the parasites are found (as
"sporozoites") in the mosquito's salivary glands.
When the Anopheles mosquito takes a blood meal on
another human, the sporozoites are injected with the
mosquito's saliva and start another human infection
when they parasitize the liver cells.
Thus the mosquito carries the disease from one human
to another (acting as a "vector").
Differently from the human host, the mosquito vector
does not suffer from the presence of the parasites.
The malaria parasite life cycle involves two hosts. During a
blood meal, a malaria-infected female Anopheles mosquito
inoculates sporozoites into the human host .
Sporozoites infect liver cells and mature into schizonts ,
which rupture and release merozoites . (Of note, in P. vivax
and P. ovale a dormant stage [hypnozoites] can persist in the
liver and cause relapses by invading the bloodstream weeks,
or even years later.)
After this initial replication in the liver (exo-erythrocytic
schizogony ), the parasites undergo asexual multiplication in
the erythrocytes (erythrocytic schizogony ).
Merozoites infect red blood cells . The ring stage
trophozoites mature into schizonts, which rupture releasing
merozoites .
Some parasites differentiate into sexual erythrocytic stages
(gametocytes) . Blood stage parasites are responsible for the
clinical manifestations of the disease.
The gametocytes, male (microgametocytes) and female
(macrogametocytes), are ingested by an Anopheles mosquito
during a blood meal .
The parasites multiplication in the mosquito is known as the
sporogonic cycle .
While in the mosquito's stomach, the microgametes
penetrate the macrogametes generating zygotes .
The zygotes in turn become motile and elongated (ookinetes)
which invade the midgut wall of the mosquito where they
develop into oocysts .
The oocysts grow, rupture, and release sporozoites , which
make their way to the mosquito's salivary glands. Inoculation
of the sporozoites into a new human host perpetuates the
malaria life cycle.
Pathogenesis
Infection with malaria parasites may result in a
wide variety of symptoms, ranging from absent or
very mild symptoms to severe disease and even
death. Malaria disease can be categorized as
uncomplicated or severe (complicated).
In general, malaria is a curable disease if
diagnosed and treated promptly and correctly.
All the clinical symptoms associated with malaria
are caused by the asexual erythrocytic or blood
stage parasites.
Pathogenesis
When the parasite develops in the erythrocyte,
numerous known and unknown waste substances
such as hemozoin pigment and other toxic factors
accumulate in the infected red blood cell.
These are dumped into the bloodstream when the
infected cells lyse and release invasive merozoites.
The hemozoin and other toxic factors such as
glucose phosphate isomerase (GPI) stimulate
macrophages and other cells to produce cytokines
and other soluble factors which act to produce
fever and rigors and probably influence other
severe pathophysiology associated with malaria.
Incubation Periode
The incubation period in most cases varies from 7 to 30
days. The shorter periods are observed most frequently
with P. falciparum and the longer ones with P. malariae.
Antimalarial drugs taken for prophylaxis by travelers can
delay the appearance of malaria symptoms by weeks or
months, long after the traveler has left the malaria-endemic
area.
Returned travelers should always remind their health-care
providers of any travel in areas where malaria occurs during
the past 12 months.
In P. vivax and P. ovale infections, patients having recovered
from the first episode of illness may suffer several
additional attacks ("relapses") after months or even years
without symptoms. Relapses occur because P. vivax and P.
ovale have dormant liver stage parasites ("hypnozoites") that
may reactivate.
Uncomplicated Malaria
The classical (but rarely observed) malaria attack lasts 6-10
hours. It consists of
1. a cold stage (sensation of cold, shivering)
2. a hot stage (fever, headaches, vomiting; seizures in young
children)
3. and finally a sweating stage (sweats, return to normal
temperature, tiredness).
Classically (but infrequently observed) the attacks occur
every second day with the "tertian" parasites ( P. falciparum,
P. vivax, and P. ovale) and every third day with the "quartan"
parasite (P. malariae).
More commonly, the patient presents with a combination of
the following symptoms:
Fever , Chills , Sweats , Headaches , Nausea and vomiting Body
aches , and General malaise
Severe Malaria
Cerebral malaria, with abnormal behavior, impairment of
consciousness, seizures, coma, or other neurologic abnormalities
Severe anemia due to hemolysis (destruction of the red blood cells)
Hemoglobinuria (hemoglobin in the urine) due to hemolysis
Acute respiratory distress syndrome (ARDS), an inflammatory
reaction in the lungs that inhibits oxygen exchange, which may
occur even after the parasite counts have decreased in response to
treatment
Abnormalities in blood coagulation
Low blood pressure caused by cardiovascular collapse
Acute kidney failure
Hyperparasitemia, where more than 5% of the red blood cells are
infected by malaria parasites
Metabolic acidosis (excessive acidity in the blood and tissue fluids),
often in association with hypoglycemia
Hypoglycemia (low blood glucose). Hypoglycemia may also occur in
pregnant women with uncomplicated malaria, or after treatment
with quinine.
Diagnosis
Microscopic Diagnosis
Malaria parasites can be identified by examining
under the microscope a drop of the patient's blood,
spread out as a "blood smear" on a microscope
slide. Prior to examination, the specimen is stained
(most often with the Giemsa stain) to give the
parasites a distinctive appearance. This technique
remains the gold standard for laboratory
confirmation of malaria. However, it depends on
the quality of the reagents, of the microscope, and
on the experience of the laboratorian.
Antigen Detection
Molecular Diagnosis
Serology
Drug Resistance Tests
Treatment
Treatment a patient with malaria depends on:
The type (species) of the infecting parasite
The area where the infection was acquired and its
drug-resistancestatus
The clinical status of the patient
Any accompanying illness or condition
Pregnancy
Drug allergies, or other medications taken by the
patient
Treatment
Prevention
chloroquine , kina, hidroklorokuin, amodiakuin (only
destroy the parasites in blood not in liver )
Fansidar pirimetamin + sulfadoksin (chloroquin
resistance areas)
Radical Treatment
Primaquine or another aminokuinolon